Global /India /Healthcare /Drug Manufacturers - Specialty & Generic /INNOVACAP
chevron_leftBack

Innova Captab Ltd.

INNOVACAP
NSE: INNOVACAP Delayed
913.45INR 1%
10.68 USD
As of 24 April 2025, Innova Captab Ltd. has a market cap of $606.68M USD, ranking #10798 globally and #727 in India. It ranks #1048 in the Healthcare sector, and #251 in the Drug Manufacturers - Specialty & Generic industry.
Global Rank
10798
Country Rank
727
Sector Rank
1048
Industry Rank
251
Key Stats
Market Cap
$606.68MUSD
51.77B INR
Enterprise Value
$633.91MUSD
54.2B INR
Revenue (TTM)
$139.64MUSD
11.92B INR
EBITDA (TTM)
$19.88MUSD
1.7B INR
Net Income (TTM)
$14.93MUSD
1.27B INR
EBITDA Margin
14%
Profit Margin
11%
PE Ratio
35.9
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Vinay Lohariwala open_in_new
Employees
1,600
Founded
2005
Website
innovacaptab.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
1% -0.2% -1.8% -10% 31% 91%
Upcoming Earnings
Earnings Date
Thu, May 29

Markets

Exchange Ticker Price
National Stock Exchange of India
MIC: XNSE
PRIMARY
INNOVACAP
Innova Captab Ltd
ISIN: INE0DUT01020
Shares Out.:
57.225M1 Shares Float: 15.714M2
TV:
SA:
YF:
GF:
BA:
MS:
913.45 INR
Bombay Stock Exchange
MIC: XBOM
544067 (INNOVACAP)
Innova Captab Ltd
ISIN: INE0DUT01020
TV:
SA:
YF:
GF:
BA:
MS:
911.65 INR
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Innova Captab Ltd.

Innova Captab Limited, an integrated pharmaceutical company, engages in the research and development, manufacture, distribution, and marketing of drugs in India and internationally. The company provides contract development and manufacturing organization services to Indian pharmaceutical companies. It is also involved in the development, manufacture, and distribution of generic formulation products, including cephalosporins, proton pump inhibitor, anticholinergic and heparin NSAIDs, analgesics and antipyretic, anticold and antiallergic, antiemetic, antidiabetic, antispasmodic, antifibrinolytic, cardiovascular, antioxidant and vitamins, antihyperuricemia and antigout, fluoroquinolone and macrolide, nootropics and neurotonics/neurotrophics, antiulcerative, antimalarial, erectile dysfunction, anxiolytic, anticonvulsant and antipsychotic, bladder and prostate disorder, antifungal, anthelmintic and antiviral, anticholinergic, anti-asthmatic, and bronchodilator products in the form of tablets, capsules, dry syrups, dry powder injection, ointments, and liquid orals. The company sells its branded generic products through its network of distributors and pharmacies, as well as online through various e-commerce pharmacy sites. Innova Captab Limited was incorporated in 2005 and is based in Panchkula, India.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (India)
Name
Market Cap diff.
Sun Pharmaceutical Industries Ltd.
SUNPHARMA
$49.13B
4.19T INR
8K%
Divi's Laboratories Ltd.
DIVISLAB
$18.39B
1.57T INR
3K%
Cipla Ltd.
CIPLA
$14.46B
1.23T INR
2K%
Torrent Pharmaceuticals Ltd.
TORNTPHARM
$13.23B
1.13T INR
2K%
Mankind Pharma Ltd.
MANKIND
$12.47B
1.06T INR
2K%
Industry: Drug Manufacturers - Specialty & Generic (Global)
Name
Market Cap diff.
Zoetis Inc.
ZTS
$67.32B
11K%
Merck KGaA
MRK
$59.42B
52.43B EUR
10K%
Takeda Pharmaceutical Company Ltd.
4502
$46.31B
6.6T JPY
8K%
Haleon plc
HLN
$45.57B
34.34B GBP
7K%
Galderma Group AG
GALD
$23.06B
19.13B CHF
4K%